AbbVie

Alkem Labs to acquire API assets from American firm AbbVie

Alkem Laboratories Ltd is set to acquire assets related to active pharmaceutical ingredient (API) Dronabinol from United States-based AbbVie Inc. ......

• Narinder Kapur